Skip Main Navigation
Page Content

Save This Event

Event Saved

Nanoparticles for Pediatric Cancer Imaging and Therapy

Stanford Child Health Research Institute

Monday, June 4, 2018 from 11:45 AM to 12:45 PM (PDT)

Nanoparticles for Pediatric Cancer Imaging and Therapy

Registration Information

Type End Quantity
Registration
LOCATION: Center for Clinical Sciences Research (CCSR), Room # 4205
Jun 1, 2018 Free  

Share Nanoparticles for Pediatric Cancer Imaging and Therapy

Event Details

** CHRI EDUCATION SEMINAR **

Nanoparticles for Pediatric Cancer Imaging and Therapy 

Heike Daldrup-Link, MD and Suchismita Mohanty, PhD

Speakers Heike Daldrup-Link, MD, PhD and Suchismita Mohanty, PhD  

Clinical contrast agents for MRI, which contain gadolinium, have been associated with nephrogenic sclerosis and gadolinium deposition in the brain. Therefore, a search for alternatives is currently underway. Ferumoxytol, an iron supplement, is FDA approved for the treatment of anemia and has been used by our group “off label” as an MR contrast agent. Drs. Heike Daldrup-Link and Suchismita Mohanty will provide an overview of the use of ferumoxytol nanoparticles for pediatric cancer imaging with MRI and PET/MRI, including safety data acquired in children thus far. The team recently demonstrated unique enhancement properties of nanoparticles in pediatric cancers, providing an immediate, non-invasive imaging test to track innate immune responses from macrophages in patients. They will also introduce novel approaches of using nanoparticles to specifically deliver therapeutic drugs to tumors, thereby providing cancer therapy without side effects to normal organs. 

Heike Daldrup-Link, MD, PhD – Dr. Daldrup-Link is a Professor of Radiology and, by courtesy, of Pediatrics (Hematology-Oncology) at Stanford University and Lucile Packard Children’s Hospital, with administrative roles as Director of Pediatric Molecular Imaging, Associate Chair for Diversity in the Radiology Department, and as Co-Director of the Cancer Imaging and Early Detection Program at the Stanford Cancer Institute. She is a past a recipient of CHRI awards, including the Transdisciplinary Initiatives Program (TIP).

 Suchismita Mohanty, PhD - Dr. Suchismita Mohanty is a Research Scientist in the Radiology Department at Stanford. Her research focuses on cancer therapy and imaging, which includes glioblastomas, osteosarcomas and breast adenocarcinomas. Dr. Mohanty develops novel tumor-targeted theranostics for disrupting tumor vasculature and tumor metabolism and deploys multi-modality imaging to monitor therapy responses to anti-tumor drugs.

Check out more CHRI Education Seminars


 About the Series

The CHRI Education Seminars highlight compelling clinical topics, innovative research, and the latest developments in maternal child health, and serves as a forum for engaging in conversations with other researchers and scientists across the community.

Seats are limited, and reservation is required. Limited lunch will be provided on a first come, first served basis. Attendees are welcome to bring their lunch to the event.

Questions about registration? Please contact Roxanna Van Norman

******************************************************

SAVE-THE-DATE! Mark your calendar for CHRI’s inaugural research symposium on November 16, 2018 featuring keynote speaker, Dr. Sean Morrison, director of the Children’s Medical Center Research Institute at University of Texas Southwestern!

Have questions about Nanoparticles for Pediatric Cancer Imaging and Therapy ? Contact Stanford Child Health Research Institute

Save This Event

Event Saved

When & Where


Center for Clinical Sciences Research (CCSR)
Room # 4205
269 Campus Drive
Stanford, CA 94305

Monday, June 4, 2018 from 11:45 AM to 12:45 PM (PDT)


  Add to my calendar

Organizer

Stanford Child Health Research Institute

Improving Clinical Research in Maternal and Child Health. The Child Health Research Institute (CHRI) at Stanford University provides a unique opportunity to advance the health of children and expectant mothers worldwide. The notable integration and physical contiguities between Lucile Packard Children's Hospital Stanford (LPCH), Stanford School of Medicine (SoM), Child Health Research Institute and importantly, the broad and deep excellence of Stanford University and its environs, creates a remarkable opportunity for innovation and bold thinking that sets us in unique position for excellence.

  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.